โ
Strictly for Research Purposes Only
This product is not intended for human consumption, diagnostic, or therapeutic use. It has not been evaluated or approved by the FDA. Misuse is strictly prohibited and may result in legal consequences.
Purity
โฅ98%
Form
Lyophilized Powder
Dosage
20mg per vial
Storage
-20ยฐC
๐ฌ Technical Specifications
Molecular Formula
C187H291N45O59
Molecular Weight
~4118.6 g/mol
Purity
โฅ98%
Packaging
20mg in sterile 2ml vial
Shelf Life
24 months when stored properly
Form
Lyophilized Powder
Storage Conditions
Store at โ20ยฐC for long-term stability. Protect from light.
Reconstitution
Requires reconstitution with sterile water or another suitable solvent
Batch Traceability
Batch Number
RET-2024-001
Mfd. Date
2024-01-15
Exp. Date
2026-01-15
Manufactured in GMP-Certified Facilities. Certificate of Analysis available on request.
Shipping & Handling
โ Shipped in temperature-controlled packaging
โ Same-day dispatch for orders before 2PM
โ Discrete, plain packaging
๐งช Scientific Background
Retatrutide is a novel investigational compound classified as a tri-agonist peptide, designed to target three key hormone receptors: GLP-1, GIP, and glucagon receptors. This triple-receptor mechanism makes it distinct in metabolic research.
Mechanism of Action: By simultaneously targeting GLP-1, GIP, and glucagon receptors, retatrutide may enhance appetite regulation, energy expenditure, and glucose metabolism. This multi-pathway approach has made it a strong point of interest in weight and metabolic research.
Research Applications
โข Weight regulation โ appetite suppression and thermogenesis
โข Type 2 diabetes โ insulin sensitivity and glucose metabolism
โข Cardiovascular health โ lipid profiles and cardiovascular risk
โข Metabolic disorders โ energy expenditure and fat distribution
Related Research Compounds
โข Tirzepatide
โข Semaglutide
โข Liraglutide
Reviews
There are no reviews yet.